J. Zhu

THU0106 In Patients with Rheumatoid Arthritis and an Inadequate Response to Methotrexate, does Body Mass Index Influence the Efficacy of Abatacept on Inflammation when Measured by Power Doppler Ultrasonography? Results from the Appraise Study

M. D’Agostino, V. Ranganath, M. le Bars, 2015 .

AB0274 Impact of Baseline Anti-Cyclic Citrullinated Peptide 2 Antibody Titre on Efficacy Outcomes Following Treatment with Subcutaneous Abatacept or Adalimumab: 2-Year Results from the Ample Trial

W. Robinson, M. Weinblatt, J. Sokolove, 2015 .

THU0114 Effect of Anti-Cyclic Citrullinated Peptide 2 Immunoglobulin M Serostatus on Efficacy Outcomes Following Treatment with Abatacept Plus Methotrexate in the Avert Trial

D. Furst, G. Burmester, T. Huizinga, 2015 .